News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Morrison Briggs
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $18.2651, valued at
$965.4k
Exercised 52,855 options to buy
@ $8.77, valued at
$463.5k
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/11/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $20.3967, valued at
$1.1M
Exercised 52,855 options to buy
@ $8.77, valued at
$463.5k
|
|
| 07/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/09/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 24,582 shares
@ $21.1791, valued at
$520.6k
Sold 28,273 shares
@ $21.1791, valued at
$598.8k
Exercised 28,273 options to buy
@ $8.77, valued at
$248k
Exercised 24,582 options to buy
@ $6.38, valued at
$156.8k
|
|
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 38,700 options to buy
@ $7.25, valued at
$280.6k
|
|
| 05/10/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $21.4072, valued at
$1.1M
Exercised 52,855 options to buy
@ $6.38, valued at
$337.2k
|
|
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/14/2023 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,854 shares
@ $22.5276, valued at
$1.2M
Exercised 52,854 options to buy
@ $6.38, valued at
$337.2k
|
|
| 03/09/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 12,175 shares
@ $0
Granted 63,310 options to buy
@ $0.68, valued at
$43.1k
Granted 34,189 options to buy
@ $1.46, valued at
$49.9k
|
|
| 03/09/2023 |
3
| Morrison Briggs (Director) has filed a Form 3 on Carisma Therapeutics Inc. |
| 02/08/2023 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,854 shares
@ $26.8269, valued at
$1.4M
Exercised 52,854 options to buy
@ $6.38, valued at
$337.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2022 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 114,339 shares
@ $23.0284, valued at
$2.6M
Sold 59,649 shares
@ $23.2529, valued at
$1.4M
Exercised 114,339 options to buy
@ $10.9, valued at
$1.2M
Exercised 59,649 options to buy
@ $10.9, valued at
$650.2k
|
|
| 09/16/2022 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 87,645 shares
@ $23.7989, valued at
$2.1M
Sold 66,775 shares
@ $24.2012, valued at
$1.6M
Sold 71,966 shares
@ $23.2195, valued at
$1.7M
Sold 53,034 shares
@ $23.2195, valued at
$1.2M
Exercised 87,645 options to buy
@ $7.2, valued at
$631k
Exercised 66,775 options to buy
@ $7.2, valued at
$480.8k
Exercised 53,034 options to buy
@ $10.9, valued at
$578.1k
Exercised 71,966 options to buy
@ $7.2, valued at
$518.2k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Granted 10,192 options to buy
@ $36.79, valued at
$375k
|
|
| 06/03/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 11,600 options to buy
@ $3.43, valued at
$39.8k
|
|
| 05/16/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 49,000 options to buy
@ $9.55, valued at
$468k
|
|
| 04/18/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Sold 3,102 shares
@ $65.2393, valued at
$202.4k
Sold 7,104 shares
@ $66.0692, valued at
$469.4k
Sold 10,754 shares
@ $67.0344, valued at
$720.9k
Exercised 16,188 options to buy
@ $16, valued at
$259k
|
|
| 04/13/2022 |
4/A
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Exercised 70,545 shares
@ $7.2, valued at
$507.9k
Exercised 3,128 shares
@ $7.2, valued at
$22.5k
Exercised 70,545 options to buy
@ $0
Exercised 3,128 options to buy
@ $0 |
|
| 04/05/2022 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 6,000 shares
@ $17.4389, valued at
$104.6k
Sold 24,500 shares
@ $17.4414, valued at
$427.3k
Sold 70,545 shares
@ $17.4579, valued at
$1.2M
Sold 3,128 shares
@ $18.2928, valued at
$57.2k
Exercised 70,545 options to buy
@ $10.9, valued at
$768.9k
Exercised 3,128 options to buy
@ $10.9, valued at
$34.1k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Sold 9,919 shares
@ $64.332, valued at
$638.1k
Sold 3,833 shares
@ $65.2417, valued at
$250.1k
Sold 5,100 shares
@ $67.2831, valued at
$343.1k
Sold 2,108 shares
@ $67.6927, valued at
$142.7k
Exercised 16,188 options to buy
@ $16, valued at
$259k
|
|
| 12/20/2021 |
4
| Morrison Briggs (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 35,156 shares
@ $20, valued at
$703.1k
Exercised 35,156 options to buy
@ $10.9, valued at
$383.2k
|
|
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Granted 7,511 options to buy
@ $78.53, valued at
$589.8k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Morrison Briggs (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 23,200 options to buy
@ $16, valued at
$371.2k
|
|
| 04/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/17/2021 |
4
| Morrison Briggs (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 4,761 shares
@ $21, valued at
$100k
|
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|